Provenance du réseau au premier degré de Rahul Shingrani
Entité | Type d'entité | Industrie | |
---|---|---|---|
ten3t Healthcare Pvt Ltd.
ten3t Healthcare Pvt Ltd. Packaged SoftwareTechnology Services Ten3t Healthcare Pvt Ltd. develops wearable medical devices. Its product Cicer collects and integrates medical grade data in real time. The company was founded by Sudhir Borgonha, Rahul Shingrani and Prasad Bhat on October 21, 2014 and is headquartered in Bangalore, India.
2
| Holding Company | Packaged Software | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rahul Shingrani via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
ClinTest International | Chief Executive Officer | ||
Angstrom Medica, Inc.
Angstrom Medica, Inc. Medical SpecialtiesHealth Technology Part of Resolve Surgical Technologies, Inc., Angstrom Medica, Inc. manufactures biomaterials and medical devices. The company is based in Woburn, MA. The company was founded by Sudhir Borgonha, Edward S. Ahn. Angstrom Medica was acquired by Resolve Surgical Technologies, Inc. on October 24, 2007. | Medical Specialties | Founder | |
CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Strand Genomics, Inc.
Strand Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Reliance Industries Ltd., Strand Genomics, Inc. is a company that uses liquid biopsy to monitor colorectal cancer. The company is based in Aurora, CO. Colorectal cancer is the second most common cancer worldwide after lung cancer. The company offers single gene testing as well as a 48-gene panel and a 152-gene panel test for colorectal cancer. A liquid biopsy approach to address the surveillance of colorectal cancer in treated patients and also to study the efficacy of the treatment regimen is under development and will be available to doctors and patients in the near future. The liquid biopsy approach has become a promising new method for monitoring therapy response, disease progression and even relapse long before any other screening method would be able to detect that the cancer has relapsed. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Martindale Pharmaceuticals Ltd.
Martindale Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Martindale Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The firm offers injectable products, pre-filled syringes, ophthalmic drops, ointments, oral solutions, and suppositories. The company was founded on September 22, 1972 and is headquartered in Romford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
St. John's Medical College | College/University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Finance | 2 |
Health Services | 2 |
Consumer Services | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Founder | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 2 |
Director/Board Member | 1 |
Relations les plus connectées
Insiders | |
---|---|
Sudhir Borgonha | 9 |
Prasad Bhat | 1 |
- Bourse
- Insiders
- Rahul Shingrani
- Connexions Sociétés